NYSE · CE

Celanese Corporation

$46.43 -$0.92 (-1.94%) 1D After hours

Key Metrics

$5.19B
Market cap
P/E · TTM
$9.49B
Revenue · TTM
−$1.10B
Net income
EPS · TTM $-10.05
Dividend yield 0.3%
Free cash flow $878.00M
Beta · 1Y 0.71
EBITDA · TTM −$354.00M
Gross margin 20.5%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 20
    From its May 1 high, the share price fell 36%.

    Peak close $69.24 on May 1; trough close $44.56 on Jul 20. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -36%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 6
    The stock moved -10.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 6
  • Mar 12
    The stock moved +14.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 12

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$5.19B
Enterprise value
Shares outstanding109.7M
52-wk range$35.13 – $70.70
Avg volume · 20D1.4M
Net cash
Book value / share$37.13
IndustryPlastic Material, Synth Resin/Rubber, Cellulos (No Glass)
ExchangeNYSE
About Celanese Corporation
IPO dateJan 21, 2005
Employees11434

Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.55
P/FCF5.91
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 20.5%
Operating -12.0%
Net -11.6%
FCF 9.2%
ROE / ROIC -23.8% · —

Financial Health

Current ratio1.38
Quick ratio0.85
Debt / equity3.53
Debt / EBITDA -40.51
Net cash
Working capital$1.65B

Cash Flow · TTM

Operating CF $1.19B
Capex −$307.00M
Free cash flow $878.00M
Buybacks
Dividends paid $13.00M
Shareholder yield 0.3%

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings